Tesamorelin vs Hexarelin
A comprehensive, data-driven comparison of Tesamorelin (Egrifta) and Hexarelin (Examorelin). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Tesamorelin Egrifta, TH9507 | Hexarelin Examorelin |
|---|---|---|
| FDA Status | FDA Approved | Not submitted |
| Category | Growth Hormone | Growth Hormone |
| Primary Use | HIV-associated lipodystrophy | Growth hormone optimization and cardiac protection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $200 - $1,500/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 2mg daily | 100-200mcg 2x daily (pulsed use recommended) |
| Frequency | Daily | Daily |
| Mechanism | Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone production | Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Emerging |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Tesamorelin is FDA-approved, while Hexarelin is currently not submitted.
- 2Hexarelin is generally more affordable ($40 - $80/mo) compared to Tesamorelin ($200 - $1,500/mo).
- 3Tesamorelin has high-quality evidence, while Hexarelin has emerging-quality evidence.
Which Is Better For...
Tesamorelin
Those seeking an FDA-approved treatment with established safety data
Hexarelin
More budget-friendly option with lower monthly costs
Tesamorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Tesamorelin | $200 - $1,500/mo | FDA Approved | Theratechnologies |
| Hexarelin | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Tesamorelin works via Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone. Hexarelin works via Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation. They differ in FDA approval status, efficacy data, and cost.
Tesamorelin typically costs $200 - $1,500/mo, while Hexarelin costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Tesamorelin is FDA-approved. Hexarelin is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Tesamorelin include Injection site reactions, Arthralgia, Peripheral edema. Common side effects of Hexarelin include Increased appetite, Cortisol elevation, Prolactin elevation. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Tesamorelin is an FDA-approved synthetic growth hormone releasing hormone analog specifically indicated for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. A new weekly reco...
View Full Tesamorelin GuideHexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects ind...
View Full Hexarelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tesamorelin and Hexarelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.